Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Lack of value of juvenile animal toxicity studies for supporting the safety of pediatric oncology phase I trials.

Visalli T, Bower N, Kokate T, Andrews PA.

Regul Toxicol Pharmacol. 2018 Jul;96:167-177. doi: 10.1016/j.yrtph.2018.05.009. Epub 2018 May 26. Review.

PMID:
29763632
2.

British Transplantation Society / Renal Association UK Guidelines for Living Donor Kidney Transplantation 2018: Summary of Updated Guidance.

Andrews PA, Burnapp L.

Transplantation. 2018 Jul;102(7):e307. doi: 10.1097/TP.0000000000002253. No abstract available.

PMID:
29688993
3.

Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.

McPherson S, Elsharkawy AM, Ankcorn M, Ijaz S, Powell J, Rowe I, Tedder R, Andrews PA.

Transplantation. 2018 Jan;102(1):15-20. doi: 10.1097/TP.0000000000001908.

PMID:
28795981
4.

Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening Diseases.

Prescott JS, Andrews PA, Baker RW, Bogdanffy MS, Fields FO, Keller DA, Lapadula DM, Mahoney NM, Paul DE, Platz SJ, Reese DM, Stoch SA, DeGeorge JJ.

Clin Pharmacol Ther. 2017 Aug;102(2):219-227. doi: 10.1002/cpt.730. Epub 2017 Jun 21. Review.

PMID:
28474798
5.

On the use of juvenile animal studies to support oncology medicine development in children.

Andrews PA, Keller DA.

Reprod Toxicol. 2016 Dec;66:128-130. doi: 10.1016/j.reprotox.2016.05.012. Epub 2016 Jun 2. No abstract available.

PMID:
27262663
6.

Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.

Manas D, Burnapp L, Andrews PA.

Transplantation. 2016 Jun;100(6):1184-90. doi: 10.1097/TP.0000000000001128. Review.

PMID:
26950721
7.

Are Benign and Borderline Brain Tumors Underreported?

Li XR, Kruchko C, Wu XC, Hsieh MC, Andrews PA, Huang B, Qiao B, Wohler B.

J Registry Manag. 2016 Winter;43(4):187-94.

PMID:
29595921
8.

Renal parenchymal calcification secondary to systemic AA amyloidosis.

Burton HM, Andrews PA.

Clin Kidney J. 2014 Oct;7(5):490. doi: 10.1093/ckj/sfu085. Epub 2014 Aug 4. No abstract available.

9.

Summary of the British Transplantation Society Guidelines for Management of the Failing Kidney Transplant.

Andrews PA; Standards Committee of the British Transplantation Society.

Transplantation. 2014 Dec 15;98(11):1130-3. doi: 10.1097/TP.0000000000000426.

PMID:
25299519
10.

Summary of the British Transplantation Society guidelines for transplantation from donors after deceased circulatory death.

Andrews PA, Burnapp L, Manas D; British Transplantation Society.

Transplantation. 2014 Feb 15;97(3):265-70. doi: 10.1097/01.TP.0000438630.13967.c0.

PMID:
24448588
11.

Effect of commonly prescribed drugs on incidence of gout.

Andrews PA.

BMJ. 2013 Oct 22;347:f6330. doi: 10.1136/bmj.f6330. No abstract available.

PMID:
24150676
12.
13.

Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.

Roberts SA, Andrews PA, Blanset D, Flagella KM, Gorovits B, Lynch CM, Martin PL, Kramer-Stickland K, Thibault S, Warner G.

Regul Toxicol Pharmacol. 2013 Dec;67(3):382-91. doi: 10.1016/j.yrtph.2013.08.017. Epub 2013 Sep 5.

PMID:
24012707
14.

Summary of the British Transplantation Society/Renal Association U.K. guidelines for living donor kidney transplantation.

Andrews PA, Burnapp L, Manas D, Bradley JA, Dudley C; British Transplantation Society; Renal Association.

Transplantation. 2012 Apr 15;93(7):666-73. doi: 10.1097/TP.0b013e318247a7b7.

PMID:
22456484
15.

Review of living kidney donor guidelines is out of date before publication.

Andrews PA.

Transplantation. 2012 Mar 15;93(5):e18; author reply e18-9. doi: 10.1097/TP.0b013e318245b2ed. No abstract available.

PMID:
22362368
16.

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.

Newsome PN, Allison ME, Andrews PA, Auzinger G, Day CP, Ferguson JW, Henriksen PA, Hubscher SG, Manley H, McKiernan PJ, Millson C, Mirza D, Neuberger JM, Oben J, Pollard S, Simpson KJ, Thorburn D, Tomlinson JW, Wyatt JS; British Transplant Society.

Gut. 2012 Apr;61(4):484-500. doi: 10.1136/gutjnl-2011-300886. Epub 2012 Jan 10. No abstract available.

PMID:
22234978
17.

Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation.

Andrews PA, Emery VC, Newstead C.

Transplantation. 2011 Dec 15;92(11):1181-7. doi: 10.1097/TP.0b013e318235c7fc. Review.

PMID:
22002346
18.

Influence of socioeconomic status and hospital type on disparities of lymph node evaluation in colon cancer patients.

Hsieh MC, Velasco C, Wu XC, Pareti LA, Andrews PA, Chen VW.

Cancer. 2012 Mar 15;118(6):1675-83. doi: 10.1002/cncr.26473. Epub 2011 Aug 31.

19.

A painful skin rash in a patient with Stage V chronic kidney disease.

Shiell KA, Andrews PA.

NDT Plus. 2011 Jun;4(3):201-4. doi: 10.1093/ndtplus/sfr012. Epub 2011 Mar 15. No abstract available.

20.

Poorer graft survival in ethnic minorities: results from a multi-centre UK study of kidney transplant outcomes.

Medcalf JF, Andrews PA, Bankart J, Bradley C, Carr S, Feehally J, Harden P, Marsh J, Newstead C, Thompson J.

Clin Nephrol. 2011 Apr;75(4):294-301.

21.

Medications to reduce cardiovascular risk after kidney transplantation.

Swift PA, Andrews PA.

Transplantation. 2011 Mar 15;91(5):492-3. doi: 10.1097/TP.0b013e318208c885. No abstract available.

PMID:
21183866
22.

Not yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required.

Swift PA, Andrews PA.

Int J Clin Pract. 2010 Sep;64(10):1331-3. doi: 10.1111/j.1742-1241.2010.02472.x. No abstract available.

PMID:
20716138
23.

Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals.

Tibbitts J, Cavagnaro JA, Haller CA, Marafino B, Andrews PA, Sullivan JT.

Regul Toxicol Pharmacol. 2010 Nov;58(2):243-51. doi: 10.1016/j.yrtph.2010.06.007. Epub 2010 Jun 15.

PMID:
20558225
24.

Comparisons of directly coded SEER Summary Stage 2000 and Collaborative Staging Derived SEER Summary Stage 2000.

Wu XC, Yu Q, Andrews PA, Ranganath P, Qiao B, Ajani U, Wohler B, Zhang Z.

J Registry Manag. 2010 Winter;37(4):137-40.

PMID:
21688742
25.

Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat.

Kerr JS, Galloway S, Lagrutta A, Armstrong M, Miller T, Richon VM, Andrews PA.

Int J Toxicol. 2010 Jan-Feb;29(1):3-19. doi: 10.1177/1091581809352111. Epub 2009 Nov 10.

PMID:
19903873
26.

Don't use urine microscopy to confirm microscopic haematuria.

Andrews PA.

BMJ. 2009 Jun 29;338:b2629. doi: 10.1136/bmj.b2629. No abstract available.

PMID:
19564198
27.

Heterotopic calcification.

Ingham VJ, Andrews PA.

NDT Plus. 2008 Aug;1(4):268-9. doi: 10.1093/ndtplus/sfn005. Epub 2008 Feb 5. No abstract available.

28.

HLA matching: still important despite modern immunosuppression.

Marsh JE, Andrews PA.

Transplantation. 2008 Feb 15;85(3):312-3. doi: 10.1097/TP.0b013e3181634a64. No abstract available.

PMID:
18301325
29.

Oversensitive dipsticks? A minimalist take on urinalysis for microscopic haematuria.

Andrews PA.

Int J Clin Pract. 2008 Mar;62(3):362-3. doi: 10.1111/j.1742-1241.2007.01670.x. No abstract available.

PMID:
18261071
30.

Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.

Wu X, Chen VW, Andrews PA, Ruiz B, Correa P.

Cancer Causes Control. 2007 Aug;18(6):585-93. Epub 2007 Apr 4.

PMID:
17406989
31.

Disposition of vorinostat, a novel histone deacetylase inhibitor and anticancer agent, in preclinical species.

Sandhu P, Andrews PA, Baker MP, Koeplinger KA, Soli ED, Miller T, Baillie TA.

Drug Metab Lett. 2007 Apr;1(2):153-61.

PMID:
19356036
32.

Renal transplantation in a patient with loin pain hematuria syndrome.

Diwakar R, Andrews PA.

Clin Nephrol. 2006 Aug;66(2):144-6.

PMID:
16939073
33.

AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases.

Lachmann HJ, Goodman HJ, Andrews PA, Gallagher H, Marsh J, Breuer S, Rowczenio DM, Bybee A, Hawkins PN.

Arthritis Rheum. 2006 Jun;54(6):2010-4.

34.

A rare and reversible cause of anaemia and renal impairment.

Phanish MK, Andrews PA.

Lancet. 2006 Apr 8;367(9517):1212. No abstract available.

PMID:
16616564
35.

Testis morphology in patients with idiopathic hypogonadotropic hypogonadism.

Kumar PA, Pitteloud N, Andrews PA, Dwyer A, Hayes F, Crowley WF Jr, Dym M.

Hum Reprod. 2006 Apr;21(4):1033-40. Epub 2006 Jan 5.

PMID:
16396935
36.

Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana.

Wu X, Chen VW, Andrews PA, Chen L, Ahmed MN, Schmidit B, Hsieh M, Fontham ET.

J La State Med Soc. 2005 Jul-Aug;157(4):188-94.

PMID:
16250368
37.

Inflammatory periodontal disease as a potential marker of cardiovascular risk.

Andrews PA.

Transplantation. 2005 Jul 15;80(1):1-2. No abstract available.

PMID:
16003223
38.

Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.

Wu X, Chen VW, Andrews PA, Chen L, Hsieh M, Fontham ET.

J La State Med Soc. 2004 Sep-Oct;156(5):255-61.

PMID:
15554095
39.

A report on the activity and clinical outcomes of renal non-heart beating donor transplantation in the United Kingdom.

Brook NR, Waller JR, Richardson AC, Andrew Bradley J, Andrews PA, Koffman G, Gok M, Talbot D, Nicholson ML.

Clin Transplant. 2004 Dec;18(6):627-33.

PMID:
15516234
40.

Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.

Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D.

Ophthalmology. 2004 Feb;111(2):352-6.

PMID:
15019389
41.

Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.

Wu X, Chen VW, Ruiz B, Andrews PA, Hsieh MC, Schmidt BA, Correa CN, Fontham ET.

J La State Med Soc. 2003 Jul-Aug;155(4):206-13.

PMID:
14506828
42.

Outcome of renal allografts from non-heart-beating donors with delayed graft function.

Gerstenkorn C, Deardon D, Koffman CG, Papalois VE, Andrews PA.

Transpl Int. 2002 Dec;15(12):660-3. Epub 2002 Oct 19.

PMID:
12478415
43.

Renal vasculitis associated with renal cell carcinoma.

Lloyd M, de Verteuil J, Andrews PA.

J R Soc Med. 2002 Jun;95(6):305-6. No abstract available.

44.

Childhood cancer in Louisiana 1988-1996.

Chen VW, Schmidt BA, Wu XC, Correa CN, Andrews PA, Hsieh MC, Ahmed MN.

J La State Med Soc. 2002 Mar-Apr;154(2):91-9.

PMID:
12014461
45.

Safety and efficacy of TNFalpha blockade in relapsing vasculitis.

Booth AD, Jefferson HJ, Ayliffe W, Andrews PA, Jayne DR.

Ann Rheum Dis. 2002 Jun;61(6):559. No abstract available.

46.

Renal transplantation.

Andrews PA.

BMJ. 2002 Mar 2;324(7336):530-4. Review. No abstract available.

47.

Breast cancer: incidence, mortality, and early detection in Louisiana, 1988-1997.

Wu XC, Andrews PA, Correa CN, Schmidt BA, Ahmed MN, Chen VW, Fontham ET.

J La State Med Soc. 2001 Apr;153(4):198-209. Review.

PMID:
11394331
48.

Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link?

Gallagher H, Andrews PA.

Drug Saf. 2001;24(6):405-12. Review.

PMID:
11368249
49.

Influence of donor/recipient size in living donor kidney transplantation.

Andrews PA, Compton F, Koffman CG.

Transplant Proc. 2001 Feb-Mar;33(1-2):1146-7. No abstract available.

PMID:
11267229
50.

Prediction of outcome in non-heart-beating kidney transplantation.

Andrews PA, Compton F, Koffman CG, Bewick M, Chang RW.

Transplant Proc. 2001 Feb-Mar;33(1-2):1121-4. No abstract available.

PMID:
11267219

Supplemental Content

Loading ...
Support Center